Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing
Diana F. Clarke(Boston Medical Center), Mark Mirochnick(Boston University), Carolee Welebob(Merck & Co., Inc., Rahway, NJ, USA (United States)), Stephen A. Spector(University of California San Diego), Hedy Teppler(Unknown), Deborah Persaud(Johns Hopkins University), Edward Handelsman(National Institutes of Health), Matthew L. Rizk(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Edward P. Acosta(University of Alabama at Birmingham), Mae Cababasay(Cancer Research And Biostatistics), JiaJia Wang(Harvard University), Yvonne J. Bryson(Oklahoma State University Center for Health Sciences)
Cited by 45
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|2004|922
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828